Caricamento...
Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine
The candidate malaria vaccine RTS,S has demonstrated 45.7% efficacy over 18 months against all clinical disease in a phase-III field study of African children. RTS,S targets the circumsporozoite protein (CSP), which is expressed on the Plasmodium sporozoite during the pre-erythrocyte stage of its li...
Salvato in:
| Pubblicato in: | Hum Vaccin Immunother |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5791571/ https://ncbi.nlm.nih.gov/pubmed/28934066 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1381809 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|